CT-G11 / Celltrion - LARVOL DELTA

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 or CT-G11 and Food Effect of CT-G20 in Human Participants (clinicaltrials.gov) - P1; N=72; Completed; Sponsor: Celltrion; Recruiting ➔ Completed

Clinical • Trial completion

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 or CT-G11 and Food Effect of CT-G20 in Human Participants (clinicaltrials.gov) - P1; N=72; Recruiting; Sponsor: Celltrion; N=48 ➔ 72; Trial completion date: Jun 2019 ➔ May 2020; Trial primary completion date: Jun 2019 ➔ May 2020

Clinical • Enrollment change • Trial completion date • Trial primary completion date